C. Navarro

发表

Lamin A Truncation in Hutchinson-Gilford Progeria

Pierre Cau, Arnold Munnich, Colin L. Stewart, 2003, Science.

Absence of T and B lymphocytes modulates dystrophic features in dysferlin deficient animal model.

G. D’Antona, M. Belicchi, Y. Torrente, 2012, Experimental cell research.

Combined treatment with statins and aminobisphosphonates extends longevity in a mouse model of human premature aging

Ignacio Varela, Sandrine Pereira, Pierre Cau, 2008, Nature Medicine.

Antisense-Based Progerin Downregulation in HGPS-Like Patients’ Cells

N. Lévy, Nathalie Da Silva, A. De Sandre-Giovannoli, 2016, Cells.

An inherited LMNA gene mutation in atypical Progeria syndrome

N. Lévy, M. Tajir, S. Elalaoui, 2012, American journal of medical genetics. Part A.

Type B mandibuloacral dysplasia with congenital myopathy due to homozygous ZMPSTE24 missense mutation

K. Mamchaoui, G. Butler-Browne, N. Lévy, 2011, European Journal of Human Genetics.

Prelamin A processing and functional effects in restrictive dermopathy

N. Lévy, C. Capanni, G. Lattanzi, 2010, Cell cycle.

LMNA, ZMPSTE24, and LBR are not mutated in scleroderma.

J. Grob, N. Lévy, C. Gaudy-Marqueste, 2009, Genetic testing and molecular biomarkers.

New ZMPSTE24 (FACE1) mutations in patients affected with restrictive dermopathy or related progeroid syndromes and mutation update

N. Lévy, D. Amor, V. Cormier-Daire, 2013, European Journal of Human Genetics.

Induced Pluripotent Stem Cells Reveal Functional Differences Between Drugs Currently Investigated in Patients With Hutchinson‐Gilford Progeria Syndrome

M. Peschanski, X. Nissan, N. Lévy, 2014, Stem cells translational medicine.

Induced Pluripotent Stem Cells Reveal Functional Differences Between Drugs Currently Investigated in PatientsWith Hutchinson-Gilford Progeria Syndrome

X. Navarro, M. Peschanski, X. Nissan, 2014 .

Cell-Based Drug Development , Screening , and Toxicology Induced Pluripotent Stem Cells Reveal Functional Differences Between Drugs Currently Investigated in PatientsWith Hutchinson-Gilford Progeria Syndrome

M. Peschanski, N. Lévy, C. Navarro, 2014 .

Shape and Texture Indexes Application to Cell nuclei Classification

Bernard Fertil, Jean-Luc Mari, Jean Sequeira, 2013, Int. J. Pattern Recognit. Artif. Intell..

N. Lévy, P. Cau, C. Navarro, 2008, Mechanisms of Ageing and Development.

Nuclear matrix, nuclear envelope and premature aging syndromes in a translational research perspective.

Pierre Cau, Nicolas Lévy, N. Lévy, 2014, Seminars in cell & developmental biology.

Molecular bases of progeroid syndromes.

Pierre Cau, Nicolas Lévy, N. Lévy, 2006, Human molecular genetics.

MG132‐induced progerin clearance is mediated by autophagy activation and splicing regulation

M. Mattei, X. Nissan, N. Lévy, 2017, EMBO molecular medicine.

Unique preservation of neural cells in Hutchinson- Gilford progeria syndrome is due to the expression of the neural-specific miR-9 microRNA.

M. Peschanski, X. Nissan, N. Lévy, 2012, Cell reports.

Metformin decreases progerin expression and alleviates pathological defects of Hutchinson–Gilford progeria syndrome cells

M. Peschanski, X. Nissan, N. Lévy, 2016, npj Aging and Mechanisms of Disease.

Loss of ZMPSTE24 (FACE-1) causes autosomal recessive restrictive dermopathy and accumulation of Lamin A precursors.

C. López-Otín, R. Hennekam, A. Wagner, 2005, Human molecular genetics.

Lamin A and ZMPSTE24 (FACE-1) defects cause nuclear disorganization and identify restrictive dermopathy as a lethal neonatal laminopathy.

R. Hennekam, A. Verloes, N. Lévy, 2004, Human molecular genetics.

Random Walk With Restart on Multiplex and Heterogeneous Biological Networks

Anaïs Baudot, Elisabeth Remy, Nicolas Levy, 2017, bioRxiv.

Full‐length dysferlin expression driven by engineered human dystrophic blood derived CD133+ stem cells

M. Belicchi, Y. Torrente, C. Navarro, 2013, The FEBS journal.

A conserved splicing mechanism of the LMNA gene controls premature aging.

C. López-Otín, J. Freije, J. Tazi, 2011, Human molecular genetics.

Splicing-Directed Therapy in a New Mouse Model of Human Accelerated Aging

I. Varela, C. López-Otín, J. Tazi, 2011, Science Translational Medicine.

A new lamin a mutation associated with acrogeria syndrome.

C. Bodemer, N. Lévy, S. Hadj-Rabia, 2014, The Journal of investigative dermatology.

Truncated prelamin A expression in HGPS-like patients: a transcriptional study

R. Wevers, N. Lévy, E. Morava, 2015, European Journal of Human Genetics.

Vulnerability of progeroid smooth muscle cells to biomechanical forces is mediated by MMP13

J. de Magalhães, A. Ori, X. Nissan, 2020, Nature Communications.

Vulnerability of progeroid smooth muscle cells to biomechanical forces is 1 mediated by MMP 13 2 3

A. Ori, X. Nissan, N. Lévy, 2020 .

Texture indexes and gray level size zone matrix. Application to cell nuclei classification

Bernard Fertil, Jean-Luc Mari, Jean Sequeira, 2009 .

Partial dysferlin reconstitution by adult murine mesoangioblasts is sufficient for full functional recovery in a murine model of dysferlinopathy

Y. Torrente, G. Cossu, I. Illa, 2010, Cell Death and Disease.

A recurrent homozygous LMNA missense variant p.Thr528Met causes atypical progeroid syndrome characterized by mandibuloacral dysostosis, severe muscular dystrophy, and skeletal deformities

A. Munnich, D. Lessel, C. Kubisch, 2023, American journal of medical genetics. Part A.

Drug screening on Hutchinson Gilford progeria pluripotent stem cells reveals aminopyrimidines as new modulators of farnesylation

M. Peschanski, J. Tournois, X. Nissan, 2016, Cell Death and Disease.